DIGITAL medication adherence company MedAdvisor has announced a new partnership with national not-for-profit health association Osteoporosis Australia (OA).
Planned to run initially for a 12 month period, the partnership will see the MedAdvisor platform communicated to Osteoporosis Australia's community including the more than 150,000 visitors to the organisation's website.
OA provides osteoporosis information and services to patients and health professionals and actively promotes improved medication adherence, which can be supported through the MedAdvisor platform, the firm said.
With over a million Australians experiencing an estimated 155,000 broken bones this year from poor bone health, the total cost of osteoporosis and associated fractures over the next decade is expected to reach $33.6 billion.
By increasing medication adherence among patients, MedAdvisor said it believes it can play a significant role in driving down these costs and at the same time helping to deliver improved patient health outcomes.
MedAdvisor says it already has about 5,200 users who live with osteoporosis and said it is also currently running a separate Patient Engagement Program to provide education for patients using a common osteoporosis medication to improve quality use of medicines.
The partnership with OA marks the fourth key relationship for the company, in addition to its partnerships with Glaucoma Australia, Epilepsy Queensland and Diabetes Australia, all representing an important contribution to the company's patient acquisition strategy, MedAdvisor said.
The above article was sent to subscribers in Pharmacy Daily's issue from 10 Oct 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 10 Oct 16
